Fundraising Fox

Aleks Radovic-Moreno

Investor

Partner at Longwood Fund · Board director at Progentos Therapeutics

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Aleks Radovic-Moreno repeatedly serves as founding or interim CEO, co-founded Be Biopharma to define engineered B cells, founded Weaver Therapeutics, and invented AST-008, which reached Phase 2.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Progentos Therapeutics

Intro paths

→

In turn, Aleks can intro founders to Progentos Therapeutics's investors below.

Progentos Therapeutics's investors · 6

Alta PartnersJackson · $1M – $12M checks · since 2024Dolby Family VenturesSan Francisco · since 2024ForbionNaarden · since 2024Longwood FundBoston · since 2024Mission BiocapitalSan Francisco · $500K checks · since 2024Service Provider CapitalVail · since 2024

Experience

  1. Longwood FundPartnercurrent2019 — present
  2. Weaver BiosciencesCo-Founder, Founding Investor, Startup CEO, BOD Chaircurrent2024 — present
  3. Progentos TherapeuticsBoard Membercurrent2024 — present
  4. Engrail TherapeuticsBoard Observercurrent2024 — present
  5. Be Biopharma, Inc.Co-Founder, Founding Investor, Startup CSOcurrent2020 — present
  6. Tome BiosciencesCo-Founder & Founding Investor2020 — 2025
  7. Pyxis OncologyBoard Member2020 — 2021
  8. Alivio TherapeuticsCo-Founder, Founding Investor, CEO2016 — 2019
  9. PureTech HealthSenior Vice President2015 — 2019
  10. Vor BiopharmaCo-Founder, Founding Investor, COO2016 — 2019
  11. ExicureResearch Scientist2013 — 2014
  12. SR OneIntern2011

Skills & more

Cell Culture9Biomedical Engineering6Research6Western BlottingMicroscopyMolecular Biology11Fluorescence MicroscopyLifesciencesNeuroscienceClinical ResearchBiotechnology13PCR
+8 moreGeneticsStatisticsScienceMedical ImagingHealthcareELISAData AnalysisConfocal Microscopy

From Aleks's professional profile.

Colleagues at Longwood Fund

Al Sandrock
Strategic Advisory Board at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund
Barry Greene
Strategic Advisory Board at Longwood Fund

Network6

Annalisa D'Andrea
Venture Partner at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
Dan Janney
Managing Director at Alta Partners
David Steinberg
General Partner at Longwood Fund
John Pribis
Principal at Longwood Fund
Lizzie Ngo
Principal at Longwood Fund

Investors connected to Aleks in public investor directories — a warm-intro map.

Frequently asked questions

Who is Aleks Radovic-Moreno?
Aleks Radovic-Moreno repeatedly serves as founding or interim CEO, co-founded Be Biopharma to define engineered B cells, founded Weaver Therapeutics, and invented AST-008, which reached Phase 2.
Where does Aleks Radovic-Moreno work?
Aleks Radovic-Moreno is Partner at Longwood Fund and Board director at Progentos Therapeutics.
What does Aleks Radovic-Moreno invest in?
Aleks Radovic-Moreno invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What check size does Aleks Radovic-Moreno write?
Aleks Radovic-Moreno typically writes checks of $100K – $5M.
Where did Aleks Radovic-Moreno go to school?
Aleks Radovic-Moreno studied at Massachusetts Institute of Technology (Doctor of Philosophy (Ph.D.), Chemical and Biomedical Engineering); Harvard Medical School (Medical Engineering & Medical Physics Program); Penn State University (Bachelor of Science (BS), Chemical Engineering).

Same school

Also attended Massachusetts Institute of Technology1,387

Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars

+ 1,381 more

Also attended Harvard Medical School143

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 137 more

Also attended Penn State University189

Kelly DonovanExecutive Assistant & Operations Associate, Revolution Growth at RevolutionFallon GoodeExecutive Assistant at March Capital PartnersCristina HohlmanPartner, Chief Financial Officer at Sapphire VenturesNick DolikInvestor at 8VCRobert SoffelRevOps Expert at Notion CapitalLouis BernemanFounding Partner at Osage University Partners

+ 183 more

Shared employers

Also worked at Weaver Biosciences1

Lizzie NgoPrincipal at Longwood Fund

Also worked at Engrail Therapeutics3

Jasper BosGeneral Partner at ForbionTiba AynechiGeneral Partner at Norwest Venture PartnersHeath LukatchPartner at Novo Holdings

Also worked at Pyxis Oncology3

David SteinbergGeneral Partner at Longwood FundLucio IannoneVice President at Leaps by BayerChristopher O'DonnellPartner at Pfizer Venture Investments

Also worked at PureTech Health9

Vikas GoyalPartner at Longwood FundDavid SteinbergGeneral Partner at Longwood FundDr. Sachin JainPresident and CEO at Team8Sachin JainObvious Champion at Obvious VenturesRaju KucherlapatiVenture Partner at Catalio Capital Management, LPJohnny HuPrincipal at Menlo Ventures

+ 3 more